Avadel Research Development from 2010 to 2026
| AVDL Stock | USD 21.64 0.02 0.09% |
Research Development | First Reported 1998-03-31 | Previous Quarter 4.3 M | Current Value 27 M | Quarterly Volatility 3.7 M |
Check Avadel Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Avadel Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.6 M, Interest Expense of 13.1 M or Selling General Administrative of 218.6 M, as well as many indicators such as Price To Sales Ratio of 7.91, Dividend Yield of 0.0 or PTB Ratio of 12.8. Avadel financial statements analysis is a perfect complement when working with Avadel Pharmaceuticals Valuation or Volatility modules.
Avadel | Research Development | Build AI portfolio with Avadel Stock |
Historical Research Development data for Avadel Pharmaceuticals serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether Avadel Pharmaceuticals PLC represents a compelling investment opportunity.
Latest Avadel Pharmaceuticals' Research Development Growth Pattern
Below is the plot of the Research Development of Avadel Pharmaceuticals PLC over the last few years. It is Avadel Pharmaceuticals' Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Avadel Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
Avadel Research Development Regression Statistics
| Arithmetic Mean | 23,728,019 | |
| Geometric Mean | 22,297,257 | |
| Coefficient Of Variation | 34.96 | |
| Mean Deviation | 6,852,677 | |
| Median | 25,089,000 | |
| Standard Deviation | 8,294,369 | |
| Sample Variance | 68.8T | |
| Range | 29.2M | |
| R-Value | (0.13) | |
| Mean Square Error | 72T | |
| R-Squared | 0.02 | |
| Significance | 0.61 | |
| Slope | (221,720) | |
| Total Sum of Squares | 1100.7T |
Avadel Research Development History
About Avadel Pharmaceuticals Financial Statements
Avadel Pharmaceuticals investors utilize fundamental indicators, such as Research Development, to predict how Avadel Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Research Development | 17.5 M | 27.2 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in discontinued. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avadel Pharmaceuticals. If investors know Avadel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Avadel Pharmaceuticals assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding Avadel Pharmaceuticals requires distinguishing between market price and book value, where the latter reflects Avadel's accounting equity. The concept of intrinsic value - what Avadel Pharmaceuticals' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Avadel Pharmaceuticals' price substantially above or below its fundamental value.
Understanding that Avadel Pharmaceuticals' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Avadel Pharmaceuticals represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Avadel Pharmaceuticals' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.